Menu
Close
.svg)
A few days ago, a friend of mine who has spent many years in pharmaceutical industry insights and analytics (I&A) texted me with a question that, strangely enough, I realized I had never directly answered in all of my writing. She asked whether I had ever written an article explaining why qualitative research still matters; and more specifically, how to explain its value to highly quantitative senior leaders who instinctively see the world through percentages, metrics, dashboards, and forecasting models. Leaders who, understandably, tend to assume that if a customer decision matters, it should somehow be fully measurable.
Her question exposed a gap I hadn’t realized was there. I started looking back over the last several years of essays and realized that while I had written extensively about behavioral science, deep listening, AI, synthetic respondents, and even the nostalgia of spending endless hours in marketing research facilities, I had never written directly about the enduring value of qualitative research itself: the slower, more methodical, conversational discipline of sitting across from another human being and trying to understand how they actually think and feel.
What prompted her question will probably feel very familiar to anyone working in I&A. She was dealing with one of those situations where a senior executive wanted to field “a quick survey” to understand something that was, in reality, a complicated thicket of emotion, institutional pressure, economics, workflow, identity, habit, and culture. Anyone who has spent enough time in this business has encountered this type of ask. I've observed that modern organizations, pharmaceutical and otherwise, increasingly condition leaders to believe that if something is important, it ought to resolve neatly into a metric. Preferably numerical. Ideally visible on a dashboard...and delivered by Monday morning.
And yet those of us who have been doing marketing research long enough to remember living in focus group facilities -- surviving largely on stale coffee, Diet Coke, and M&M’s behind the glass -- know that human behavior rarely cooperates with this appetite for behavioral neatness. The deeper motivations behind decisions are often layered, contradictory, emotional, contextual, and (according to the recent revolution in behavioral science) only partially conscious even to the respondent themselves.
So, on this rainy weekend in Philadelphia, I found myself sitting down to write something I probably should have written years ago: an essay about the enduring value of qualitative research in a business world increasingly obsessed with quantification.
Her text arrived at exactly the right moment. Over the course of this past week, I had several conversations with clients, and a common phrase kept surfacing repeatedly: integrated insights. It is hardly a new concept, but it increasingly feels like the organizing principle of modern I&A. Pharmaceutical insights teams are now expected to synthesize an almost overwhelming number of evidence streams -- claims data, CRM analytics, market tracking, social listening, epidemiology, forecasting, behavioral science, qualitative research, and increasingly AI-generated analyses -- into something coherent enough to guide real business decisions.
That is no easy task.
And while “integrated insights” may sound elegant in PowerPoint, what it often means operationally is that organizations are awash in information while simultaneously starving for interpretation. Most companies do not suffer from a lack of data anymore. Quite the opposite. The modern problem is figuring out what any of it actually means when placed in the messy context of real human behavior.
At the same time, I&A teams are under pressure to move faster, support more stakeholders, cover more brands, and deliver increasingly definitive points of view with fewer resources. Against that backdrop, it becomes tempting to over-rely on whatever is easiest to quantify. Numbers feel stable. Dashboards carry authority. Forecast models create the comforting impression that behavior is somehow fully knowable if only enough variables are added to the equation. And yet, the questions that clients continue struggling with are often profoundly human ones:
Those are not really data problems. They are interpretation problems.
And this is precisely where qualitative research becomes so valuable. Not as a substitute for quantification, but as the connective tissue that gives the numbers meaning. The best qualitative work helps unpack the emotional logic, contextual pressures, belief systems, habits, and organizational dynamics sitting beneath the observable behavior. It transforms the chart back into a human story.
When you break it down to its essence, quantitative research is extraordinarily good at identifying what is happening. Qualitative research is often much better at helping explain what we at ThinkGen call “the deep why’s.”
A dashboard can display declining adoption curves. An ATU study can identify shifts in intent. Claims data can reveal treatment discontinuation patterns with remarkable precision. But numbers alone often struggle to illuminate the emotional and contextual architecture sitting underneath those behaviors: the human logic (or illogic) that explains why the behavior is occurring in the first place. They are questions about psychology, workflow, belief systems, habit, institutional culture, and emotional challenges.
This is where good qualitative work remains a necessity.
Strong qualitative interviewing requires moderators with enough industry fluency to understand the science, enough psychological instinct to recognize emotional subtext, and enough curiosity to keep probing after the first answer is given. Often the first answer that comes out of a respondent's mouth is not the real answer. It is the polished answer. The rational answer. The answer respondents believe they are supposed to give.
The more revealing insight often arrives twenty minutes later, once the respondent relaxes enough to start speaking more honestly about the frustrations, contradictions, pressures, and accumulated experiences that actually shape behavior. A good moderator will skillfully leverage those contradictions to glean deeper and deeper echelons of truth - truth the respondent may not necessarily have consciously processed.
And it is in these moments that qualitative research becomes extraordinarily valuable.
One of the more persistent misconceptions about qualitative research is that it exists mainly to “support” quantitative findings after the fact, as though qual were simply there to provide a few colorful quotes to place around the charts. In reality, some of the most valuable qualitative work happens well before the measurement begins.
Effective qualitative research helps pharma companies identify what they should even be measuring in the first place. It surfaces the language physicians naturally use to describe a disease state. It reveals operational barriers companies had not fully appreciated. It exposes emotional tensions underlying prescribing behavior. It clarifies where workflow friction exists and where conviction erodes. Sometimes it reveals that the organization has framed the problem incorrectly from the start.
That last point matters more than many leaders realize.
I cannot count the number of times I have entered a qualitative study thinking the central challenge facing a brand was messaging or differentiation, only to discover twenty interviews later that the real issue was workflow integration, emotional discomfort, uncertainty around sequencing, or simply the fact that the physician did not see enough patients to build confidence with the product.
Those are not minor tactical observations. They are strategic epiphanies. And they often emerge only through the slower, human process of exploration through conversation.
One of the things one learns after enough years in qualitative work is that people are remarkably poor narrators of their own behavior. We contradict ourselves constantly. We rationalize decisions after the fact. We explain emotionally driven choices in highly rational language. We hold multiple, conflicting beliefs simultaneously and somehow manage to function perfectly well despite the inconsistency.
Despite all of their training and clinical experience, physicians are no different.
A doctor may insist she is “highly data driven” and then spend the next thirty minutes describing how one particularly difficult patient experience permanently shaped her comfort level with a therapy. A patient may claim that adherence is extremely important while simultaneously describing a daily routine that makes adherence almost impossible. An executive may insist the market is behaving irrationally when, in reality, the organization has misunderstood the emotional reality of the treatment experience.
This is precisely why deep qualitative work requires perseverance and patience: listening and discussing. Iterating. Rethinking. It's not a clean and straightforward process.
We have to set our audience's expectations: the first fifteen minutes of an interview are often largely performance. Respondents give polished answers, professional answers, socially acceptable answers. The real interview often begins only once some level of trust has formed and the respondent starts speaking less formally and more honestly about the real factors and oftentimes contradictions shaping their decisions.
That is difficult work to scale. It is also difficult work to automate. It's why I think the idea of synthetic or simulated respondents are still a long way off.
There is a strange irony in modern business. As organizations accumulate more data, interpretation becomes more important, not less.
Patterns are easier than ever to detect. AI can identify correlations at extraordinary speed. Dashboards update continuously. Forecast models grow increasingly sophisticated. But the existence of more data does not automatically create more understanding.
In some ways, it creates the opposite problem.
Organizations become overwhelmed by information while starving for synthesis. Teams begin mistaking precision for comprehension. A metric expressed to one decimal place starts to feel authoritative even when the underlying behavior remains poorly understood.
This is why the best I&A organizations increasingly think in terms of integration rather than methodology silos. Quantitative and qualitative approaches are not competitors. They are complementary ways of understanding reality.
One tells you the pattern. The other helps explain the human beings creating it.
None of this is an argument against quantification. Pharmaceutical strategy would collapse without analytics, forecasting, epidemiology, and rigorous measurement. The issue is not whether numbers matter. Clearly they do.
The issue is whether we sometimes overestimate what numbers alone can explain.
Human behavior is contextual. Emotional. Habitual. Contradictory. Social. Institutional. Cultural. And occasionally irrational in ways that only make sense once someone has taken the time to sit down and truly listen.
These are just some of the reasons why qualitative research still matters. Not as accoutrements around the charts, but as the mechanism that helps explain the world those charts are attempting to describe.
And perhaps that is the simplest way to think about it. The dashboard may tell you what is happening. But somewhere behind that dashboard is still a human story trying to explain the why.
